Melanin-concentrating hormone in the Locus Coeruleus aggravates helpless behavior in stressed rats
- PMID: 31376444
- DOI: 10.1016/j.bbr.2019.112120
Melanin-concentrating hormone in the Locus Coeruleus aggravates helpless behavior in stressed rats
Abstract
Animal studies have shown that antagonists of receptor 1 of Melanin-Concentrating Hormone (MCH-R1) elicit antidepressive-like behavior, suggesting that MCH-R1 might be a novel target for the treatment of depression and supports the hypothesis that MCHergic signaling regulates depressive-like behaviors. Consistent with the evidence that MCHergic neurons send projections to dorsal and median raphe nuclei, we have previously demonstrated that MCH microinjections in both nuclei induced a depressive-like behavior. Even though MCH neurons also project to Locus Coeruleus (LC), only a few studies have reported the behavioral and neurochemical effect of MCH into the LC. We studied the effects of MCH (100 and 200 ng) into the LC on coping-stress related behaviors associated with depression, using two different behavioral tests: the forced swimming test (FST) and the learned helplessness (LH). To characterize the functional interaction between MCH and the noradrenergic LC system, we also evaluated the neurochemical effects of MCH (100 ng) on the extracellular levels of noradrenaline (NA) in the medial prefrontal cortex (mPFC), an important LC terminal region involved in emotional processing. MCH administration into the LC elicited a depressive-like behavior evidenced in both paradigms. Interestingly, in the LH, MCH (100) elicited a significant increase in escape failures only in stressed animals. A significant decrease in prefrontal levels of NA was observed after MCH microinjection into the LC. Our results demonstrate that increased MCH signaling into the LC triggers depressive-like behaviors, especially in stressed animals. These data further corroborate the important role of MCH in the neurobiology of depression.
Keywords: Forced swimming test; Learned helplessness; Noradrenaline; Prefrontal cortex.
Copyright © 2019 Elsevier B.V. All rights reserved.
Similar articles
-
Melanin-Concentrating Hormone (MCH) and MCH-R1 in the Locus Coeruleus May Be Involved in the Regulation of Depressive-Like Behavior.Int J Neuropsychopharmacol. 2018 Dec 1;21(12):1128-1137. doi: 10.1093/ijnp/pyy088. Int J Neuropsychopharmacol. 2018. PMID: 30335150 Free PMC article.
-
Prodepressive effect induced by microinjections of MCH into the dorsal raphe: time course, dose dependence, effects on anxiety-related behaviors, and reversion by nortriptyline.Behav Pharmacol. 2014 Aug;25(4):316-24. doi: 10.1097/FBP.0000000000000056. Behav Pharmacol. 2014. PMID: 25006977
-
Melanin-concentrating hormone projections to the dorsal raphe nucleus: An immunofluorescence and in vivo microdialysis study.J Chem Neuroanat. 2016 Mar;72:16-24. doi: 10.1016/j.jchemneu.2015.11.010. Epub 2015 Dec 12. J Chem Neuroanat. 2016. PMID: 26686290
-
Melanin-concentrating hormone: A promising target for antidepressant treatment.Pharmacol Biochem Behav. 2025 May;250:173999. doi: 10.1016/j.pbb.2025.173999. Epub 2025 Mar 11. Pharmacol Biochem Behav. 2025. PMID: 40081601 Review.
-
Melanin-concentrating hormone MCH1 receptor antagonists: a potential new approach to the treatment of depression and anxiety disorders.CNS Drugs. 2006;20(10):801-11. doi: 10.2165/00023210-200620100-00002. CNS Drugs. 2006. PMID: 16999451 Review.
Cited by
-
Chronic Stress-Induced Elevation of Melanin-Concentrating Hormone in the Locus Coeruleus Inhibits Norepinephrine Production and Associated With Depression-Like Behaviors in Rats.Int J Neuropsychopharmacol. 2024 Jan 1;27(1):pyad069. doi: 10.1093/ijnp/pyad069. Int J Neuropsychopharmacol. 2024. PMID: 38135278 Free PMC article.
-
The melanin-concentrating hormone system as a target for the treatment of sleep disorders.Front Neurosci. 2022 Sep 13;16:952275. doi: 10.3389/fnins.2022.952275. eCollection 2022. Front Neurosci. 2022. PMID: 36177357 Free PMC article. Review.
-
Gene expression signatures differentiating major depressive disorder from subsyndromal symptomatic depression.Aging (Albany NY). 2021 May 8;13(9):13124-13137. doi: 10.18632/aging.202995. Epub 2021 May 8. Aging (Albany NY). 2021. PMID: 33971621 Free PMC article.
-
Prolactin-Releasing Peptide Contributes to Stress-Related Mood Disorders and Inhibits Sleep/Mood Regulatory Melanin-Concentrating Hormone Neurons in Rats.J Neurosci. 2023 Feb 1;43(5):846-862. doi: 10.1523/JNEUROSCI.2139-21.2022. Epub 2022 Dec 23. J Neurosci. 2023. PMID: 36564184 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous